The Role of the Gut Microbiome in Colorectal Cancer Development and Therapy Response
Open accessThe DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) is the third most common cancer worldwide and the leading cause of cancer-related deaths. Recently, several studies have demonstrated that gut microbiota can alter CRC susceptibility and progression by modulating mechanisms such as inflammation and DNA damage, and by producing metabolites involved in tumor progression or suppression. Dysbiosis of gut microbiota has been observed in patients with CRC, with a decrease in commensal bacterial species (butyrate-producing bacteria) and an enrichment of detrimental bacterial populations (pro-inflammatory opportunistic pathogens). CRC is characterized by altered production of bacterial metabolites directly involved in cancer metabolism including short-chain fatty acids and polyamines. Emerging evidence suggests that diet has an important impact on the risk of CRC development. The intake of high-fiber diets and the supplementation of diet with polyunsaturated fatty acids, polyphenols and probiotics, which are known to regulate gut microbiota, could be not only a potential mechanism for the reduction of CRC risk in a primary prevention setting, but may also be important to enhance the response to cancer therapy when used as adjuvant to conventional treatment for CRC. Therefore, a personalized modulation of the pattern of gut microbiome by diet may be a promising approach to prevent the development and progression of CRC and to improve the efficacy of antitumoral therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766
Linking long-term dietary patterns with gut microbial enterotypes
Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y.-Y., Keilbaugh, S. A., Bewtra, M., Knights, D., Walters, W. A., Knight, R., et al. (2011) · Science · doi:10.1126/science.1208344 · Cited by 6,513
Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671
The impact of the gut microbiota on human health: an integrative view
Clemente, J. C., Ursell, L. K., Parfrey, L. W., & Knight, R. (2012) · Cell · doi:10.1016/j.cell.2012.01.035 · Cited by 3,710
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
Vétizou, M., Pitt, J. M., Daillère, R., Lepage, P., Waldschmitt, N., Flament, C., Rusakiewicz, S., Routy, B., Roberti, M. P., Duong, C. P. M., et al. (2015) · Science · doi:10.1126/science.aad1329 · Cited by 3,488 · cited 1×
“In addition, the disruption of microbiota in MC38 colon carcinoma-grafted mice with a broad-spectrum antibiotics impaired tumor response to anti-CTLA4 immunotherapies [91].”
BackgroundGut microbiota, metabolites and host immunity
Rooks, M. G., & Garrett, W. S. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.42 · Cited by 3,409
Bacterial Community Variation in Human Body Habitats Across Space and Time
Costello, E. K., Lauber, C. L., Hamady, M., Fierer, N., Gordon, J. I., & Knight, R. (2009) · Science · doi:10.1126/science.1177486 · Cited by 3,231 · cited 1×
“Although the composition of microbiota is influenced by genetics [4] and may be considered relatively stable within healthy adults over time [5], there is a large variation in the microbiota composition among individuals; this variation is conditioned by different external environmental factors such as diet, chemical…”
BackgroundThe gut microbiota, bacterial metabolites and colorectal cancer
Louis, P., Hold, G. L., & Flint, H. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3344 · Cited by 2,816
Energy contributions of volatile fatty acids from the gastrointestinal tract in various species
Bergman, E. N. (1990) · Physiological Reviews · doi:10.1152/physrev.1990.70.2.567 · Cited by 2,750
Review article: the role of butyrate on colonic function
HAMER, H. M., JONKERS, D., VENEMA, K., VANHOUTVIN, S., TROOST, F. J., & BRUMMER, R. ‐. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03562.x · Cited by 2,721
Kostic, A. D., Chun, E., Robertson, L., Glickman, J. N., Gallini, C. A., Michaud, M., Clancy, T. E., Chung, D. C., Lochhead, P., Hold, G. L., et al. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.007 · Cited by 2,718 · cited 2×
“Emerging evidence suggests that in animal models gut microbiota may contribute to CRC development through the production of microbial metabolites that interact with the host-immune system and induce the release of genotoxic virulence factors [1,2,15,16].”
BackgroundRubinstein, M. R., Wang, X., Liu, W., Hao, Y., Cai, G., & Han, Y. W. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.07.012 · Cited by 2,476
Singh, N., Gurav, A., Sivaprakasam, S., Brady, E., Padia, R., Shi, H., Thangaraju, M., Prasad, P. D., Manicassamy, S., Munn, D. H., et al. (2014) · Immunity · doi:10.1016/j.immuni.2013.12.007 · Cited by 2,368 · cited 1×
“In addition, butyrate can induce the expansion of T reg lymphocytes to regulate the local immune response and suppressing colonic inflammation and carcinogenesis [74] (Figure 1).”
BackgroundCommensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
Iida, N., Dzutsev, A., Stewart, C. A., Smith, L., Bouladoux, N., Weingarten, R. A., Molina, D. A., Salcedo, R., Back, T., Cramer, S., et al. (2013) · Science · doi:10.1126/science.1240527 · Cited by 2,251
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
Yu, T., Guo, F., Yu, Y., Sun, T., Ma, D., Han, J., Qian, Y., Kryczek, I., Sun, D., Nagarsheth, N., et al. (2017) · Cell · doi:10.1016/j.cell.2017.07.008 · Cited by 2,198
How colonization by microbiota in early life shapes the immune system
Gensollen, T., Iyer, S. S., Kasper, D. L., & Blumberg, R. S. (2016) · Science · doi:10.1126/science.aad9378 · Cited by 2,044
NLRP6 Inflammasome Regulates Colonic Microbial Ecology and Risk for Colitis
Elinav, E., Strowig, T., Kau, A. L., Henao-Mejia, J., Thaiss, C. A., Booth, C. J., Peaper, D. R., Bertin, J., Eisenbarth, S. C., Gordon, J. I., et al. (2011) · Cell · doi:10.1016/j.cell.2011.04.022 · Cited by 2,024
Benefits of polyphenols on gut microbiota and implications in human health
Cardona, F., Andrés-Lacueva, C., Tulipani, S., Tinahones, F. J., & Queipo-Ortuño, M. I. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.05.001 · Cited by 1,605
Self-citationAnalysis of Fusobacterium persistence and antibiotic response in colorectal cancer
Bullman, S., Pedamallu, C. S., Sicinska, E., Clancy, T. E., Zhang, X., Cai, D., Neuberg, D., Huang, K., Guevara, F., Nelson, T., et al. (2017) · Science · doi:10.1126/science.aal5240 · Cited by 1,574
Gut microbiome development along the colorectal adenoma-carcinoma sequence
Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., Zhang, D., Xia, H., Xu, X., Jie, Z., et al. (2015) · Nature Communications · doi:10.1038/ncomms7528 · Cited by 1,506 · cited 1×
“These changes might produce enrichment in pro-inflammatory opportunistic pathogens and a decrease in butyrate-producing bacteria, which may lead to an imbalance in intestinal homeostasis (dysbiosis) that could ultimately lead to tumor formation [11,20,21].”
BackgroundMicrobes in Gastrointestinal Health and Disease
Neish, A. S. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.10.080 · Cited by 1,386
Effects of Dietary Fiber and Its Components on Metabolic Health
Lattimer, J. M., & Haub, M. D. (2010) · Nutrients · doi:10.3390/nu2121266 · Cited by 1,333 · cited 2×
“2010 [93]) Dietary Fiber (Arabinoxylan, Inulin, β-glucan, Pectin, Bran, Cellulose, Resistant Starch) In vivo Human ↑ Excretion of bile acids, ↑ Production of fecal SCFAs ↑ Antioxidants ↓ Cancer prevalence”
BackgroundEpidemiology of cancer of the colon and rectum
Burkitt, D. P. (1971) · Cancer · doi:10.1002/1097-0142(197107)28:1<3::aid-cncr2820280104>3.0.co;2-n · Cited by 1,333
Adenoma–linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth
Grivennikov, S. I., Wang, K., Mucida, D., Stewart, C. A., Schnabl, B., Jauch, D., Taniguchi, K., Yu, G.-Y., Österreicher, C. H., Hung, K. E., et al. (2012) · Nature · doi:10.1038/nature11465 · Cited by 1,327
Benson, A. K., Kelly, S. A., Legge, R., Ma, F., Low, S. J., Kim, J., Zhang, M., Oh, P. L., Nehrenberg, D., Hua, K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1007028107 · Cited by 1,314
Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers
Wang, T., Cai, G., Qiu, Y., Fei, N., Zhang, M., Pang, X., Jia, W., Cai, S., & Zhao, L. (2012) · The ISME Journal · doi:10.1038/ismej.2011.109 · Cited by 1,287 · cited 2×
“microbiota composition compared with those with advanced stage tumours (definitive CRC) [19,23], suggesting that gut microbiota could participate in tumor progression.”
BackgroundYu, J., Feng, Q., Wong, S. H., Zhang, D., Liang, Q. Y., Qin, Y., Tang, L., Zhao, H., Stenvang, J., Li, Y., et al. (2017) · Gut · doi:10.1136/gutjnl-2015-309800 · Cited by 1,253
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
Fusobacterium nucleatum — symbiont, opportunist and oncobacterium
Brennan, C. A., & Garrett, W. S. (2019) · Nature Reviews Microbiology · doi:10.1038/s41579-018-0129-6 · Cited by 1,205 · cited 2×
“nucleatum has also been associated with resistance to the CRC chemotherapy agent oxaliplatin by inducing authophagy via Toll-like receptor 4 [51].”
BackgroundBingham, S. A., Day, N. E., Luben, R., Ferrari, P., Slimani, N., Norat, T., Clavel-Chapelon, F., Kesse, E., Nieters, A., Boeing, H., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13174-1 · Cited by 1,111
Human Intestinal Lumen and Mucosa-Associated Microbiota in Patients with Colorectal Cancer
Chen, W., Liu, F., Ling, Z., Tong, X., & Xiang, C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039743 · Cited by 1,034
Thomas, A. M., Manghi, P., Asnicar, F., Pasolli, E., Armanini, F., Zolfo, M., Beghini, F., Manara, S., Karcher, N., Pozzi, C., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0405-7 · Cited by 1,030
Vaishnava, S., Behrendt, C. L., Ismail, A. S., Eckmann, L., & Hooper, L. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808723105 · Cited by 1,019
Fat, fibre and cancer risk in African Americans and rural Africans
O’Keefe, S. J. D., Li, J. V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., Posma, J. M., Kinross, J., Wahl, E., Ruder, E., et al. (2015) · Nature Communications · doi:10.1038/ncomms7342 · Cited by 982
Human Gut Microbiome and Risk for Colorectal Cancer
Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., Goedert, J. J., Hayes, R. B., & Yang, L. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt300 · Cited by 947
A bacterial driver–passenger model for colorectal cancer: beyond the usual suspects
Tjalsma, H., Boleij, A., Marchesi, J. R., & Dutilh, B. E. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2819 · Cited by 903
Gut microbiota imbalance and colorectal cancer
Gagnière, J. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i2.501 · Cited by 845
Allen, I. C., TeKippe, E. M., Woodford, R.-M. T., Uronis, J. M., Holl, E. K., Rogers, A. B., Herfarth, H. H., Jobin, C., & Ting, J. P.-Y. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100050 · Cited by 826
Polyamine metabolism and cancer: treatments, challenges and opportunities
Casero, R. A., Murray Stewart, T., & Pegg, A. E. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0050-3 · Cited by 817
Impact of Omega-3 Fatty Acids on the Gut Microbiota
Costantini, L., Molinari, R., Farinon, B., & Merendino, N. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122645 · Cited by 741
Gut mucosal microbiome across stages of colorectal carcinogenesis
Nakatsu, G., Li, X., Zhou, H., Sheng, J., Wong, S. H., Wu, W. K. K., Ng, S. C., Tsoi, H., Dong, Y., Zhang, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms9727 · Cited by 701
Microbiota organization is a distinct feature of proximal colorectal cancers
Dejea, C. M., Wick, E. C., Hechenbleikner, E. M., White, J. R., Mark Welch, J. L., Rossetti, B. J., Peterson, S. N., Snesrud, E. C., Borisy, G. G., Lazarev, M., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406199111 · Cited by 700
The Gut Microbiome Modulates Colon Tumorigenesis
Zackular, J. P., Baxter, N. T., Iverson, K. D., Sadler, W. D., Petrosino, J. F., Chen, G. Y., & Schloss, P. D. (2013) · mBio · doi:10.1128/mbio.00692-13 · Cited by 629
Goodwin, A. C., Shields, C. E. D., Wu, S., Huso, D. L., Wu, X., Murray-Stewart, T. R., Hacker-Prietz, A., Rabizadeh, S., Woster, P. M., Sears, C. L., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010203108 · Cited by 612
Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients
Rafter, J., Bennett, M., Caderni, G., Clune, Y., Hughes, R., Karlsson, P. C., Klinder, A., O'Riordan, M., O'Sullivan, G. C., Pool-Zobel, B., et al. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.2.488 · Cited by 589
Chemoprevention of colon cancer by calcium, vitamin D and folate: molecular mechanisms
Lamprecht, S. A., & Lipkin, M. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1144 · Cited by 583
Inflammation and colorectal cancer: colitis-associated neoplasia
Grivennikov, S. I. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-012-0352-6 · Cited by 551
Deehan, E. C., Yang, C., Perez-Muñoz, M. E., Nguyen, N. K., Cheng, C. C., Triador, L., Zhang, Z., Bakal, J. A., & Walter, J. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.01.006 · Cited by 539
Galdeano, C. M., & Perdigón, G. (2006) · Clinical and Vaccine Immunology · doi:10.1128/cvi.13.2.219-226.2006 · Cited by 535
Fusobacterium nucleatum promotes colorectal cancer by inducing Wnt/β‐catenin modulator Annexin A1
Rubinstein, M. R., Baik, J. E., Lagana, S. M., Han, R. P., Raab, W. J., Sahoo, D., Dalerba, P., Wang, T. C., & Han, Y. W. (2019) · EMBO reports · doi:10.15252/embr.201847638 · Cited by 525
Dupaul-Chicoine, J., Yeretssian, G., Doiron, K., Bergstrom, K. S. B., McIntire, C. R., LeBlanc, P. M., Meunier, C., Turbide, C., Gros, P., Beauchemin, N., et al. (2010) · Immunity · doi:10.1016/j.immuni.2010.02.012 · Cited by 517
Meyskens, F. L., McLaren, C. E., Pelot, D., Fujikawa-Brooks, S., Carpenter, P. M., Hawk, E., Kelloff, G., Lawson, M. J., Kidao, J., McCracken, J., et al. (2008) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0042 · Cited by 517
Fusobacterium Is Associated with Colorectal Adenomas
McCoy, A. N., Araújo-Pérez, F., Azcárate-Peril, A., Yeh, J. J., Sandler, R. S., & Keku, T. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0053653 · Cited by 515
Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer
Coker, O. O., Nakatsu, G., Dai, R. Z., Wu, W. K. K., Wong, S. H., Ng, S. C., Chan, F. K. L., Sung, J. J. Y., & Yu, J. (2019) · Gut · doi:10.1136/gutjnl-2018-317178 · Cited by 511
Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products
Rechner, A. R., Smith, M. A., Kuhnle, G., Gibson, G. R., Debnam, E. S., Srai, S. K. S., Moore, K. P., & Rice-Evans, C. A. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2003.09.022 · Cited by 511
Watson, H., Mitra, S., Croden, F. C., Taylor, M., Wood, H. M., Perry, S. L., Spencer, J. A., Quirke, P., Toogood, G. J., Lawton, C. L., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-314968 · Cited by 506
Zhang, L. S., & Davies, S. S. (2016) · Genome Medicine · doi:10.1186/s13073-016-0296-x · Cited by 500
Zheng, D.-W., Dong, X., Pan, P., Chen, K.-W., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2019) · Nature Biomedical Engineering · doi:10.1038/s41551-019-0423-2 · Cited by 495 · cited 1×
“nucleatum population and allowing the butyrate-producing bacteria to increase their abundance at the same time [37].”
BackgroundIntestinal floras of populations that have a high risk of colon cancer
Moore, W. E., & Moore, L. H. (1995) · Applied and Environmental Microbiology · doi:10.1128/aem.61.9.3202-3207.1995 · Cited by 486
Donohoe, D. R., Holley, D., Collins, L. B., Montgomery, S. A., Whitmore, A. C., Hillhouse, A., Curry, K. P., Renner, S. W., Greenwalt, A., Ryan, E. P., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0501 · Cited by 474
Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients
Wu, N., Yang, X., Zhang, R., Li, J., Xiao, X., Hu, Y., Chen, Y., Yang, F., Lu, N., Wang, Z., et al. (2013) · Microbial Ecology · doi:10.1007/s00248-013-0245-9 · Cited by 454
Quercetin and Cancer Chemoprevention
Gibellini, L., Pinti, M., Nasi, M., Montagna, J. P., De Biasi, S., Roat, E., Bertoncelli, L., Cooper, E. L., & Cossarizza, A. (2011) · Evidence-Based Complementary and Alternative Medicine · doi:10.1093/ecam/neq053 · Cited by 449
Salcedo, R., Worschech, A., Cardone, M., Jones, Y., Gyulai, Z., Dai, R.-M., Wang, E., Ma, W., Haines, D., O'hUigin, C., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20100199 · Cited by 429 · cited 2×
“Butyrate has been shown to be able to induce IL-18 production in intestinal epithelial cells by activating GPR109a receptor, which stimulates the mucosal tissue repair through the regulation of the production and availability of IL-22 [69].”
BackgroundModulation of the Intestinal Microbiota Alters Colitis-Associated Colorectal Cancer Susceptibility
Uronis, J. M., Mühlbauer, M., Herfarth, H. H., Rubinas, T. C., Jones, G. S., & Jobin, C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006026 · Cited by 425
Molecular characterization of mucosal adherent bacteria and associations with colorectal adenomas
Shen, X. J., Rawls, J. F., Randall, T. A., Burcall, L., Mpande, C., Jenkins, N., Jovov, B., Abdo, Z., Sandler, R. S., & Keku, T. O. (2010) · Gut Microbes · doi:10.4161/gmic.1.3.12360 · Cited by 418 · cited 1×
“These changes might produce enrichment in pro-inflammatory opportunistic pathogens and a decrease in butyrate-producing bacteria, which may lead to an imbalance in intestinal homeostasis (dysbiosis) that could ultimately lead to tumor formation [11,20,21].”
BackgroundÖsterlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., Kouri, M., Elomaa, I., & Joensuu, H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603990 · Cited by 405
A survey of modulation of gut microbiota by dietary polyphenols
Dueñas, M., Muñoz-González, I., Cueva, C., Jiménez-Girón, A., Sánchez-Patán, F., Santos-Buelga, C., Moreno-Arribas, M. V., & Bartolomé, B. (2015) · BioMed Research International · doi:10.1155/2015/850902 · Cited by 396
Phenolic Compounds in Cereal Grains and Their Health Benefits
Dykes (2007) · Cereal Foods World · doi:10.1094/cfw-52-3-0105 · Cited by 393
Alterations in Enteric Virome Are Associated With Colorectal Cancer and Survival Outcomes
Nakatsu, G., Zhou, H., Wu, W. K. K., Wong, S. H., Coker, O. O., Dai, Z., Li, X., Szeto, C.-H., Sugimura, N., Lam, T. Y.-T., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.04.018 · Cited by 386
Hibberd, A. A., Lyra, A., Ouwehand, A. C., Rolny, P., Lindegren, H., Cedgård, L., & Wettergren, Y. (2017) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2017-000145 · Cited by 373
Metabolism Links Bacterial Biofilms and Colon Carcinogenesis
Johnson, C. H., Dejea, C. M., Edler, D., Hoang, L. T., Santidrian, A. F., Felding, B. H., Ivanisevic, J., Cho, K., Wick, E. C., Hechenbleikner, E. M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.04.011 · Cited by 351
Modulation of adipose tissue inflammation by bioactive food compounds
Siriwardhana, N., Kalupahana, N. S., Cekanova, M., LeMieux, M., Greer, B., & Moustaid-Moussa, N. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.013 · Cited by 345
Hu, B., Elinav, E., Huber, S., Strowig, T., Hao, L., Hafemann, A., Jin, C., Wunderlich, C., Wunderlich, T., Eisenbarth, S. C., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307575110 · Cited by 326
Mehta, R. S., Nishihara, R., Cao, Y., Song, M., Mima, K., Qian, Z. R., Nowak, J. A., Kosumi, K., Hamada, T., Masugi, Y., et al. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2016.6374 · Cited by 325 · cited 3×
“2017 [102] Dietary Fiber (whole grains) In vivo Human ↓ Risk of developing Fusobacterium nucleatum-positive CRC”
BackgroundInfluentialChen, H.-M., Yu, Y.-N., Wang, J.-L., Lin, Y.-W., Kong, X., Yang, C.-Q., Yang, L., Liu, Z.-J., Yuan, Y.-Z., Liu, F., et al. (2013) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.112.046607 · Cited by 321
Schatzkin, A., Mouw, T., Park, Y., Subar, A. F., Kipnis, V., Hollenbeck, A., Leitzmann, M. F., & Thompson, F. E. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.5.1353 · Cited by 317 · cited 3×
“2007 [96] Dietary Fiber (whole grains) In vivo Human ↑Whole grain food consumption ↓ Risk of CRC (modest)”
BackgroundInfluentialTofalo, R., Cocchi, S., & Suzzi, G. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00016 · Cited by 306
The Role of the Microbiota in Inflammation, Carcinogenesis, and Cancer Therapy
Dzutsev, A., Goldszmid, R. S., Viaud, S., Zitvogel, L., & Trinchieri, G. (2015) · European Journal of Immunology · doi:10.1002/eji.201444972 · Cited by 300
Diagnostic potential and interactive dynamics of the colorectal cancer virome
Hannigan, G. D., Duhaime, M. B., Ruffin, M. T., Koumpouras, C. C., & Schloss, P. D. (2018) · mBio · doi:10.1128/mbio.02248-18 · Cited by 298 · cited 2×
“This would favor the penetration of oncogenic bacteria in the intestinal lumen, triggering the inflammatory immune response and promoting the transformation of tumor cells [36].”
BackgroundVinderola, G., Perdigón, G., Duarte, J., Farnworth, E., & Matar, C. (2006) · Cytokine · doi:10.1016/j.cyto.2007.01.003 · Cited by 291
Probiotic-derived ferrichrome inhibits colon cancer progression via JNK-mediated apoptosis
Konishi, H., Fujiya, M., Tanaka, H., Ueno, N., Moriichi, K., Sasajima, J., Ikuta, K., Akutsu, H., Tanabe, H., & Kohgo, Y. (2016) · Nature Communications · doi:10.1038/ncomms12365 · Cited by 287 · cited 3×
“casei strain ATCC 334 produced ferrichrome, a molecule that inhibits the progression of colon cancer by inducing the apoptosis of cancer cells via c-Jun N-terminal kinase pathway [179].”
BackgroundInfluentialThe mechanisms by which polyamines accelerate tumor spread
Soda, K. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-95 · Cited by 270
Mechanisms linking dietary fiber, gut microbiota and colon cancer prevention
Zeng, H. (2014) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v6.i2.41 · Cited by 266
Microbiome, Inflammation, and Cancer
Francescone, R., Hou, V., & Grivennikov, S. I. (2014) · The Cancer Journal · doi:10.1097/ppo.0000000000000048 · Cited by 266
Colon Cancer: A Civilization Disorder
Watson, A. J. M., & Collins, P. D. (2011) · Digestive Diseases · doi:10.1159/000323926 · Cited by 257
Viljoen, K. S., Dakshinamurthy, A., Goldberg, P., & Blackburn, J. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119462 · Cited by 256 · cited 1×
“microbiota composition compared with those with advanced stage tumours (definitive CRC) [19,23], suggesting that gut microbiota could participate in tumor progression.”
BackgroundBrown, D. G., Rao, S., Weir, T. L., O’Malia, J., Bazan, M., Brown, R. J., & Ryan, E. P. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0151-y · Cited by 254
The colibactin warhead crosslinks DNA
Vizcaino, M. I., & Crawford, J. M. (2015) · Nature Chemistry · doi:10.1038/nchem.2221 · Cited by 247 · cited 1×
“coli toxin (colibactin toxin) causes DNA crosslinks and double strand DNA breaks [49], and Salmonella protein AvrA has recently been shown to induce β-catenin signaling and enhance colonic tumorigenesis by activating STAT3 pathway in a colon cancer mouse model [48].”
BackgroundDietary Fiber and Colorectal Cancer Risk: A Nested Case-Control Study Using Food Diaries
Dahm, C. C., Keogh, R. H., Spencer, E. A., Greenwood, D. C., Key, T. J., Fentiman, I. S., Shipley, M. J., Brunner, E. J., Cade, J. E., Burley, V. J., et al. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq092 · Cited by 241
The gut microbiota in conventional and serrated precursors of colorectal cancer
Peters, B. A., Dominianni, C., Shapiro, J. A., Church, T. R., Wu, J., Miller, G., Yuen, E., Freiman, H., Lustbader, I., Salik, J., et al. (2016) · Microbiome · doi:10.1186/s40168-016-0218-6 · Cited by 230
Bhat, M. I., & Kapila, R. (2017) · Nutrition Reviews · doi:10.1093/nutrit/nux001 · Cited by 228
Dietary and Gut Microbiota Polyamines in Obesity- and Age-Related Diseases
Ramos-Molina, B., Queipo-Ortuño, M. I., Lambertos, A., Tinahones, F. J., & Peñafiel, R. (2019) · Frontiers in Nutrition · doi:10.3389/fnut.2019.00024 · Cited by 226 · cited 1×
“This is particularly important in the case of CRC, which is surrounded by intestinal bacteria that are able to produce high levels of polyamines [60,61].”
BackgroundSelf-citationThe Role of Curcumin in Modulating Colonic Microbiota During Colitis and Colon Cancer Prevention
McFadden, R.-M. T., Larmonier, C. B., Shehab, K. W., Midura-Kiela, M., Ramalingam, R., Harrison, C. A., Besselsen, D. G., Chase, J. H., Caporaso, J. G., Jobin, C., et al. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000522 · Cited by 225
Resveratrol Suppresses Colitis and Colon Cancer Associated with Colitis
Cui, X., Jin, Y., Hofseth, A. B., Pena, E., Habiger, J., Chumanevich, A., Poudyal, D., Nagarkatti, M., Nagarkatti, P. S., Singh, U. P., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0117 · Cited by 219
Bishehsari, F., Engen, P. A., Preite, N. Z., Tuncil, Y. E., Naqib, A., Shaikh, M., Rossi, M., Wilber, S., Green, S. J., Hamaker, B. R., et al. (2018) · Genes · doi:10.3390/genes9020102 · Cited by 214
Yuan, L., Zhang, S., Li, H., Yang, F., Mushtaq, N., Ullah, S., Shi, Y., An, C., & Xu, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.165 · Cited by 208
Gut microbiota accelerate tumor growth via c-jun and STAT3 phosphorylation in APC Min/+ mice
Li, Y., Kundu, P., Seow, S. W., de Matos, C. T., Aronsson, L., Chin, K. C., Kärre, K., Pettersson, S., & Greicius, G. (2012) · Carcinogenesis · doi:10.1093/carcin/bgs137 · Cited by 206
Fiber Intake and Survival After Colorectal Cancer Diagnosis
Song, M., Wu, K., Meyerhardt, J. A., Ogino, S., Wang, M., Fuchs, C. S., Giovannucci, E. L., & Chan, A. T. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3684 · Cited by 197 · cited 2×
“Moreover, a higher intake of dietary fiber and whole grains after CRC diagnosis has been associated with better survival rates [100] Moen et al.”
BackgroundLong-term use of antibiotics and risk of colorectal adenoma
Cao, Y., Wu, K., Mehta, R., Drew, D. A., Song, M., Lochhead, P., Nguyen, L. H., Izard, J., Fuchs, C. S., Garrett, W. S., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-313413 · Cited by 192
Dysbiosis of Fungal Microbiota in the Intestinal Mucosa of Patients with Colorectal Adenomas
Luan, C., Xie, L., Yang, X., Miao, H., Lv, N., Zhang, R., Xiao, X., Hu, Y., Liu, Y., Wu, N., et al. (2015) · Scientific Reports · doi:10.1038/srep07980 · Cited by 190
Chang, W.-C. L., Chapkin, R. S., & Lupton, J. R. (1998) · The Journal of Nutrition · doi:10.1093/jn/128.3.491 · Cited by 185
Suppression of colon carcinogenesis by bioactive compounds in grapefruit
Vanamala, J., Leonardi, T., Patil, B. S., Taddeo, S. S., Murphy, M. E., Pike, L. M., Chapkin, R. S., Lupton, J. R., & Turner, N. D. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi318 · Cited by 180
Drago, L. (2019) · Microorganisms · doi:10.3390/microorganisms7030066 · Cited by 171
Zhang, J., Haines, C. F., Watson, A. J. M., Hart, A. R., Platt, M. J., Pardoll, D. M., Cosgrove, S. E., Gebo, K. A., & Sears, C. L. (2018) · Gut · doi:10.1136/gutjnl-2019-318593 · Cited by 171
Saffarian, A., Mulet, C., Regnault, B., Amiot, A., Tran-Van-Nhieu, J., Ravel, J., Sobhani, I., Sansonetti, P. J., & Pédron, T. (2019) · mBio · doi:10.1128/mbio.01315-19 · Cited by 164
Dysbiosis signature of mycobiota in colon polyp and colorectal cancer
Gao, R., Kong, C., Li, H., Huang, L., Qu, X., Qin, N., & Qin, H. (2017) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-017-3085-6 · Cited by 161
Gamble, L. D., Purgato, S., Murray, J. E., Xiao, L., Yu, D. M. T., Hanssen, K. M., Giorgi, F. M., Carter, D. R., Gifford, A. J., Valli, E., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau1099 · Cited by 161
Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer
Mileo, A. M., Nisticò, P., & Miccadei, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00729 · Cited by 160
Role of gut microbiota in the pathogenesis of colorectal cancer; a review article.
Sherafat, S. J., Alebouyeh, M., Moghim, S., Amoli, H. A., & Ghasemian-Safaei, H. (2018) · Gastroenterology and hepatology from bed to bench. · doi:10.22037/ghfbb.v0i0.1052 · Cited by 155
Buhrmann, C., Shayan, P., Kraehe, P., Popper, B., Goel, A., & Shakibaei, M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.08.105 · Cited by 153
Chang (2018) · doi:10.3389/fmicb.2018.00983 · Cited by 152
Lee, Y., Sung, B., Kang, Y. J., Kim, D. H., JANG, J.-Y., Hwang, S. Y., Kim, M.-J., Lim, H. S., Yoon, J.-H., Chung, H. Y., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2339 · Cited by 145
Anti-inflammatory effects of freeze-dried black raspberry powder in ulcerative colitis
Montrose, D. C., Horelik, N. A., Madigan, J. P., Stoner, G. D., Wang, L., Bruno, R. S., Park, H. J., Giardina, C. A., & Rosenberg, D. W. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq248 · Cited by 143
Role of gut microbiota in the pathogenesis of colorectal cancer; a review article.
Jahani‐Sherafat, S., Alebouyeh, M., Moghim, S., Amoli, H. A., & Ghasemian-Safaei, H. (2018) · Europe PMC (PubMed Central) · Cited by 143
Xavier, C. P. R., Lima, C. F., Rohde, M., & Pereira‐Wilson, C. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1641-9 · Cited by 142
Paul, S., DeCastro, A., Lee, H. J., Smolarek, A. K., So, J. Y., Simi, B., Wang, C.-X., Zhou, R., Rimando, A. M., & Suh, N. (2010) · Carcinogenesis · doi:10.1093/carcin/bgq004 · Cited by 136
Dik, V. K., van Oijen, M. G. H., Smeets, H. M., & Siersema, P. D. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3828-0 · Cited by 135
Shakibaei, M., Buhrmann, C., Kraehe, P., Shayan, P., Lueders, C., & Goel, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085397 · Cited by 132
Manipulation of the Gut Microbiota Reveals Role in Colon Tumorigenesis
Zackular, J. P., Baxter, N. T., Chen, G., & Schloss, P. D. (2015) · mSphere · doi:10.1128/msphere.00001-15 · Cited by 132
Aglago, E. K., Huybrechts, I., Murphy, N., Casagrande, C., Nicolas, G., Pischon, T., Fedirko, V., Severi, G., Boutron‐Ruault, M., Fournier, A., et al. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.06.031 · Cited by 132
Hatakka, K., Holma, R., El-Nezami, H. S., Suomalainen, T., Kuisma, M., Saxelin, M., Poussa, T. A., Mykkänen, H. M., & Korpela, R. (2008) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2008.09.010 · Cited by 130
Montalban‐Arques, A., & Scharl, M. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.09.050 · Cited by 129
Probiotics modify human intestinal mucosa-associated microbiota in patients with colorectal cancer
Gao, Z., Guo, B., Gao, R., Zhu, Q., Wu, W., & Qin, H. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4124 · Cited by 125
Cueva, C., Silva, M., Pinillos, I., Bartolomé, B., & Moreno-Arribas, M. V. (2020) · Nutrients · doi:10.3390/nu12030625 · Cited by 125
Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer
Lin, C., Cai, X., Zhang, J., Wang, W., Sheng, Q., Hua, H., & Zhou, X. (2018) · Digestion · doi:10.1159/000494052 · Cited by 121
Marine ω-3 polyunsaturated fatty acid intake and survival after colorectal cancer diagnosis
Song, M., Zhang, X., Meyerhardt, J. A., Giovannucci, E. L., Ogino, S., Fuchs, C. S., & Chan, A. T. (2016) · Gut · doi:10.1136/gutjnl-2016-311990 · Cited by 118
Omega-3 polyunsaturated fatty acids as adjuvant therapy of colorectal cancer
Volpato, M., & Hull, M. A. (2018) · Cancer and Metastasis Reviews · doi:10.1007/s10555-018-9744-y · Cited by 117
Habitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts
Nimptsch, K., Zhang, X., Cassidy, A., Song, M., O’Reilly, É. J., Lin, J., Pischon, T., Rimm, E. B., Willett, W. C., Fuchs, C. S., et al. (2015) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.117507 · Cited by 114
Gut microbiota, chemotherapy and the host: the influence of the gut microbiota on cancer treatment
Pouncey, A. L., Scott, A. J., Alexander, J. L., Marchesi, J. R., & Kinross, J. K. (2018) · ecancermedicalscience · doi:10.3332/ecancer.2018.868 · Cited by 114
Ng, Y., Barhoumi, R., Tjalkens, R. B., Fan, Y., Kolar, S. S. N., Wang, N., Lupton, J. R., & Chapkin, R. S. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi163 · Cited by 111
Golkhalkhali, B., Rajandram, R., Paliany, A. S., Ho, G. F., Ishak, W. Z. W., Johari, C. S., & Chin, K. F. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12758 · Cited by 107
Piazzi, G., D’Argenio, G., Prossomariti, A., Lembo, V., Mazzone, G., Candela, M., Biagi, E., Brigidi, P., Vitaglione, P., Fogliano, V., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28853 · Cited by 104
Kostovcikova, K., Kverka, M., Zakostelska, Z. J., Hudcovic, T., Hrnčíř, T., Štëpánková, R., Rossmann, P., Rídl, J., Kostovčík, M., Mrázek, J., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281330a · Cited by 103
The Bacteroides fragilis Toxin Binds to a Specific Intestinal Epithelial Cell Receptor
Wu, S., Shin, J. W., Zhang, G., Cohen, M. B., Franco, A. A., & Sears, C. L. (2006) · Infection and Immunity · doi:10.1128/iai.00060-06 · Cited by 103
Impact of antibiotic exposure on the risk of colorectal cancer
Boursi, B., Haynes, K., Mamtani, R., & Yang, Y. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3765 · Cited by 102
Human papillomavirus infection and colorectal cancer risk: a meta‐analysis
Damin, D. C., Ziegelmann, P. K., & Damin, A. P. S. (2013) · Colorectal Disease · doi:10.1111/codi.12257 · Cited by 95
Microbial influences on the small intestinal response to radiation injury
Packey, C. D., & Ciorba, M. A. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283361927 · Cited by 92
Hansen, L., Skeie, G., Landberg, R., Lund, E., Palmqvist, R., Johansson, I., Dragsted, L. O., Egeberg, R., Johnsen, N. F., Christensen, J., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.26381 · Cited by 92
Venâncio, V. P., Cipriano, P., Kim, H., Antunes, L. M. G., Talcott, S. T., & Mertens‐Talcott, S. U. (2016) · Food & Function · doi:10.1039/c6fo01498d · Cited by 89
Bongers, G., Pacer, M. E., Geraldino, T. H., Chen, L., He, Z., Hashimoto, D., Furtado, G. C., Ochando, J., Kelley, K. A., Clemente, J. C., et al. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20131587 · Cited by 85
Rodríguez‐Ramiro, I., Ramos, S., López‐Oliva, M. E., Agís-Torres, Á., Bravo, L., Goya, L., & Martín, M. Á. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512004862 · Cited by 84
Wang, J., Chang, C., Lin, J., Wu, L., Chuang, L., & Lai, M. (2014) · International Journal of Cancer · doi:10.1002/ijc.28738 · Cited by 81
Wang, Z., Zhang, L., Ni, Z., Sun, J., Gao, H. Q., Cheng, Z., Xu, J., & Yin, P. (2015) · Tumor Biology · doi:10.1007/s13277-015-3636-3 · Cited by 77
WAN, Y., XIN, Y., ZHANG, C., WU, D., DING, D., TANG, L., OWUSU, L., BAI, J., & LI, W. (2014) · Oncology Letters · doi:10.3892/ol.2014.1959 · Cited by 76
Hessels, J., Kingma, A. W., Ferwerda, H., Keu, J., Berg, G. A. V. D., & Muskiet, F. A. J. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430632 · Cited by 72
Lee, J. Y., Sim, T.-B., Lee, J., & Na, H. (2017) · Clinical Nutrition Research · doi:10.7762/cnr.2017.6.3.147 · Cited by 71
Intestinal microbiota: a novel perspective in colorectal cancer biotherapeutics
Ding, C., Tang, W., Fan, X., & Wu, G. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s170626 · Cited by 69
Polyamine deprivation: a new tool in cancer treatment.
Quémener, V., Blanchard, Y., Chamaillard, L., Havouis, R., Cipolla, B. G., & Moulinoux, J.-P. (1994) · PubMed · Cited by 68
Relationship between intestinal microbiota and colorectal cancer
Çıpe, G., İdiz, U. O., Fırat, Y. D., & Bektaşoğlu, H. K. (2015) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v7.i10.233 · Cited by 68
Zamora‐Ros, R., Barupal, D. K., Rothwell, J. A., Jenab, M., Fedirko, V., Romieu, I., Aleksandrova, K., Overvad, K., Kyrø, C., Tjønneland, A. M., et al. (2016) · International Journal of Cancer · doi:10.1002/ijc.30582 · Cited by 68
Cho, Y., Turner, N. D., Davidson, L. A., Chapkin, R. S., Carroll, R. J., & Lupton, J. R. (2014) · Experimental Biology and Medicine · doi:10.1177/1535370213514927 · Cited by 67
Raj, K. P., Zell, J. A., Rock, C. L., McLaren, C. E., Zoumas‐Morse, C., Gerner, E. W., & Meyskens, F. L. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.15 · Cited by 66
Gut Microbiota Influences Experimental Outcomes in Mouse Models of Colorectal Cancer
Leystra, A. A., & Clapper, M. L. (2019) · Genes · doi:10.3390/genes10110900 · Cited by 63
Hakim, L., Alias, E., Makpol, S., Ngah, W. Z. W., Morad, N. A., & Yusof, Y. A. M. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.11.4651 · Cited by 62
Liang, S., Xu, L., Zhang, D., & Wu, Z. (2016) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2016.15375 · Cited by 62
Coelho, T. R., de Almeida, L. P., & Lazo, P. A. (2010) · Virology Journal · doi:10.1186/1743-422x-7-42 · Cited by 60
Colon cancer cell chemosensitisation by fish oil emulsion involves apoptotic mitochondria pathway
Granci, V., Cai, F., Lecumberri, E., Clerc, A., Dupertuis, Y. M., & Pichard, C. (2012) · British Journal Of Nutrition · doi:10.1017/s000711451200308x · Cited by 60
Moen, B., Henjum, K., Måge, I., Knutsen, S. H., Rud, I., Hetland, R. B., & Paulsen, J. E. (2016) · PLoS ONE · doi:10.1371/journal.pone.0155402 · Cited by 57
Cho, Y., Turner, N. D., Davidson, L. A., Chapkin, R. S., Carroll, R. J., & Lupton, J. R. (2012) · Experimental Biology and Medicine · doi:10.1258/ebm.2012.012244 · Cited by 55
Song, M., Nishihara, R., Wu, K., Qian, Z. R., Kim, S. A., Sukawa, Y., Mima, K., Inamura, K., Masuda, A., Yang, J., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv007 · Cited by 50
Simons, C. C. J. M., Hughes, L., Arts, I. C. W., Goldbohm, R. A., van den Brandt, P. A., & Weijenberg, M. P. (2009) · International Journal of Cancer · doi:10.1002/ijc.24645 · Cited by 50
Efficacy of PD-1 Blockade in Tumors with MMR Deficiency
Lee, V., & Le, D. T. (2015) · Immunotherapy · doi:10.2217/imt.15.97 · Cited by 48
Possibility of preventing colorectal carcinogenesis with probiotics.
Ohara, T., Yoshino, K., & Kitajima, M. (2010) · PubMed · Cited by 48
Cai, F., Sorg, O., Granci, V., Lecumberri, E., Miralbell, R., Dupertuis, Y. M., & Pichard, C. (2013) · Clinical Nutrition · doi:10.1016/j.clnu.2013.04.005 · Cited by 47
Sánchez, M. C., Ribeiro‐Vidal, H., Esteban‐Fernández, A., Bartolomé, B., Figuero, E., Moreno-Arribas, M. V., Sanz, M., & Herrera, D. (2019) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-019-2533-5 · Cited by 47
Martin, O. C. B., Lin, C. C., Naud, N., Taché, S., Raymond‐Letron, I., Corpet, D. E., & Pierre, F. H. F. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2015.976317 · Cited by 45
Expression profile of polyunsaturated fatty acids in colorectal cancer
Yang, K. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i8.2405 · Cited by 44
A dietary pattern that is associated with C-peptide and risk of colorectal cancer in women
Fung, T. T., Hu, F. B., Schulze, M. B., Pollak, M., Wu, T., Fuchs, C. S., & Giovannucci, E. L. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9969-y · Cited by 44
The association between colorectal cancer and prior antibiotic prescriptions: case control study
Armstrong, D., Dregan, A., Ashworth, M. J., White, P. T., McGee, C., & de Lusignan, S. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0701-5 · Cited by 40
Linsalata, M., Russo, F., Cavallini, A., Berloco, P. B., & Leo, A. D. (1993) · Diseases of the Colon & Rectum · doi:10.1007/bf02238593 · Cited by 39
Rani, I., Vaiphei, K., & Agnihotri, N. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2497-6 · Cited by 33
Ebadi, M., Field, C. J., Lehner, R. S., & Mazurak, V. C. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-017-0638-8 · Cited by 33
Sanyaolu, L. N., Oakley, N. J., Nurmatov, U. B., Dolwani, S., & Ahmed, H. (2019) · Colorectal Disease · doi:10.1111/codi.14921 · Cited by 31
Triff, K., Kim, E., & Chapkin, R. S. (2015) · Current Pharmacology Reports · doi:10.1007/s40495-014-0005-7 · Cited by 30
Hong, M. Y., Turner, N. D., Murphy, M. E., Carroll, R. J., Chapkin, R. S., & Lupton, J. R. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-15-0147 · Cited by 30
Bozkurt, H. S., Quigley, E. M. M., & Kara, B. (2019) · SAGE Open Medicine · doi:10.1177/2050312119825784 · Cited by 30
The impact of gut microbiota manipulation with antibiotics on colon tumorigenesis in a murine model
Lee, J. G., Eun, C. S., Jo, S. V., Lee, A.-R., Park, C. H., & Han, D. S. (2019) · PLoS ONE · doi:10.1371/journal.pone.0226907 · Cited by 27
Mechanisms by Which Pleiotropic Amphiphilic n−3 PUFA Reduce Colon Cancer Risk
Chapkin, R. S., DeClercq, V., Kim, E., Fuentes, N. R., & Fan, Y. (2014) · Current Colorectal Cancer Reports · doi:10.1007/s11888-014-0241-6 · Cited by 26
Miene, C., Klenow, S., Veeriah, S., Richling, E., & Glei, M. (2009) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800444 · Cited by 22
Rani, I., Sharma, B., Kumar, S., Kaur, S., & Agnihotri, N. (2017) · Tumor Biology · doi:10.1177/1010428317695019 · Cited by 22
Abdel-Rahman, O. M., Ghosh, S., & Walker, J. W. T. (2020) · Clinical & Translational Oncology · doi:10.1007/s12094-020-02301-1 · Cited by 17
Antibiotic use and colorectal cancer: a causal association?
Ma, W., & Chan, A. T. (2019) · Gut · doi:10.1136/gutjnl-2019-319792 · Cited by 14
Sebe, M., Tsutsumi, R., Yamaguchi, S., Horikawa, Y. T., Harada, N., Oyama, T., Kakuta, N., Tanaka, K., Tsutsumi, Y. M., Nakaya, Y., et al. (2016) · BMC Nutrition · doi:10.1186/s40795-016-0057-7 · Cited by 8
Preclinical animal tumor models to study prevention of colon cancer recurrence by curcumin
Majumdar, A. P. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814704-7.00012-x · Cited by 5
Cited by
Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T., & Przybyłowicz, K. E. (2021) · Cancers · doi:10.3390/cancers13092025 · Cited by 921
The Intestinal Microbiota and Colorectal Cancer
Cheng, Y., Ling, Z., & Li, L. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.615056 · Cited by 582
Probiotics Regulate Gut Microbiota: An Effective Method to Improve Immunity
Wang, X., Zhang, P., & Zhang, X. (2021) · Molecules · doi:10.3390/molecules26196076 · Cited by 529
Butyrate-producing human gut symbiont, Clostridium butyricum , and its role in health and disease
Stoeva, M. K., Garcia-So, J., Justice, N., Myers, J., Tyagi, S., Nemchek, M., McMurdie, P. J., Kolterman, O., & Eid, J. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1907272 · Cited by 518
Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy
Chrysostomou, D., Roberts, L. A., Marchesi, J. R., & Kinross, J. M. (2023) · Gastroenterology · doi:10.1053/j.gastro.2022.10.018 · Cited by 283
Metadata
- Authors
- Sánchez-Alcoholado, L., Ramos-Molina, B., Otero, A., Laborda-Illanes, A., Ordóñez, R., Medina, J. A., Gómez-Millán, J., & Queipo-Ortuño, M. I.
- Venue
- Cancers
- Publisher
- MDPI AG
- Published
- 2020-05-29
- Volume
- 12
- Issue
- 6
- Pages
- 1406
- ISSN
- 2072-6694 (ISSN-L)
- OpenAlex
- W3031126723
- Cited by
- 337
- References
- 184
- FWCI
- 13.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.